![Rick Pollack, American Hospital Association CEO and President standing in front of United States flag and the AHA seal.](/sites/default/files/2022-04/AT-Rick-Pollack-Perspective-2022-News-900x400.jpg)
Pfizer asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 65 and older who received an initial booster of any authorized or approved COVID-19 vaccine, based on data from Israel showing the additional booster reduced infections and severe illness when the omicron variant was circulating.